The study dataset, with clinical and laboratory results, is provided in Table and Legend S1. Fifteen patients, 14 of them with ocular involvement, were DIF-negative of whom seven had antibodies to basement membrane zone epitopes. MMP-affected sites varied: eight were ocular only, ten oral only, 15 oral and ocular only and 22 multisite. Exons 2 and 3 in HLA-DQB1 were fully analysed in 54/55 patients and 39/41 controls (Table 1a) . The frequency of HLA-DQB1*03:01 was increased (p c = < 0.01) in 36/54 (67%) of MMP patients (13 homozygous and 23 heterozygous) compared to 13/39 (33%) controls (two homozygous and 11 heterozygous, Table 1a ). Exon 2 of HLA-DRB1 was also fully analysed in 54/55 patients and 40/41 controls; HLA-DRB1*03:01 was decreased (p = < 0.01, p c = 0.045 ,  Table 1b ). Additionally, we compared the frequency of HLA-DQB1*0301 with controls for different sites of involvement showing that HLA-DQB1*0301 was increased in all subgroups except for ocular only MMP. Compared to controls, DIF-positive MMP had significantly increased HLA-DQB1*0301 (p = 0.00009) but this difference was not significant for either DIF-negative MMP (p = 0.113) or for DIF-positive ocular only MMP. Some studies have described a correlation of HLA-DQB1*03:01 with ocular and oral MMP or in ocular only MMP, whereas others have shown HLA-DQB1*03:01 to be associated with multisite MMP [2] . In this study, the association of HLA-DQB1*0301 with MMP was lower than in the largest reported study [2] (p c < 0.00000028), possibly due to our inclusion of eight patients without detectable tissue-bound or serum antibodies, who were excluded from the latter study [2] . In ocular only MMP 50% are DIF-negative but have a phenotype that both progresses and responds to therapy in the same way as DIF-positive cases [3, 4] . DIF-negative ocular MMP may result from inadequate test sensitivity, because of the small volumes of tissue involved, to dominance of an autoreactive T-cell mediated over a autoantibody-mediated disease [4] or because this is a different disease subset. We included our DIF-negative cases because to leave these out of this analysis disregards a group of cases which do not fit criteria for any other disease.
In our prospectively characterized cohort the association with HLA-DQB1*0301, HLA-DQB1*02, and HLA-DRB1*11 was corroborated, whereas HLA-DRB1*0301 was identified as a potentially protective allele, which requires confirmation in a larger study. In the first step of the analysis the gene frequencies for the allel groups of HLA-DQB1 (2-6) and HLA-DRB1 (1, 3-5, 7-9, and 11-16) were compared and in the second step, only significant alleles were further analysed regarding specific HLA-protein (e.g., HLA-DRB1*11) and compared. The p-value is given for comparisons of HLA gene frequencies, between cases and controls, using Fisher's exact test for each allele. The p c value is the probability value after using the Benjamini-Hochberg correction for multiple testing.
ND not done a All patients with HLA-DRB1*03 expressed the specific protein HLA-DRB1*0301.
